Cargando…
Development of drugs for severe malaria in children
Over 90% of deaths attributable to malaria are in African children under 5 years old. Yet, new treatments are often tested primarily in adult patients and extrapolations have proven to be sometimes invalid, especially in dosing regimens. For studies in severe malaria an additional complication is th...
Autores principales: | Cheah, Phaik Yeong, Parker, Michael, Dondorp, Arjen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039823/ https://www.ncbi.nlm.nih.gov/pubmed/27620923 http://dx.doi.org/10.1093/inthealth/ihw038 |
Ejemplares similares
-
Community engagement for malaria elimination in the Greater Mekong Sub-region: a qualitative study among malaria researchers and policymakers
por: Kaehler, Nils, et al.
Publicado: (2022) -
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021) -
Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations
por: Lubell, Yoel, et al.
Publicado: (2014) -
The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study
por: Peto, Thomas J, et al.
Publicado: (2018) -
Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)